Medisca
Medisca is a privately held pharmaceutical compounding solutions provider founded in 1989, distributing 2,000+ APIs, chemicals, and compounding supplies to pharmacies, outsourcing facilities, hospitals, and healthcare providers globally, supported by formulation, education, and compliance services.
- Company typePrivate
- Founded1989
- HeadquartersPlattsburgh, United States
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What Medisca does
Medisca is a privately held pharmaceutical compounding solutions provider founded in 1989 and headquartered in New York, USA, with 251-500 employees and a global operational footprint spanning North America, Asia Pacific, Europe, South America, the Middle East, and Africa. The company sells a portfolio of over 2,000 products to compounding pharmacies (503A), FDA-registered outsourcing facilities (503B), hospitals, clinics, physicians, contract manufacturers, laboratories, wholesalers, telehealth providers, and the cannabis industry. Its core product lines include active pharmaceutical ingredients (APIs), bases and vehicles, capsules, chemicals, controlled substances, devices, equipment, flavors, colors, oils, and lab supplies, complemented by state-of-the-art mixing and milling technologies, analytical testing capabilities, and formulation support services.
The company's technology stack is centered on physical pharmaceutical compounding infrastructure, standardized operating procedures, and quality-assured ingredient sourcing rather than software platforms. Supporting the product business is a digital ecosystem comprising a B2B e-commerce portal (medisca.com with localized country storefronts), a formula library, BUDs (Beyond Use Date) library, studies library, Compounding 101 educational resources, and a Controlled Substances Ordering System (CSOS) registration platform. The company also operates an education catalog spanning self-paced online learning, seminars, webinars, hands-on lab training, and provider portals, which functions as both a customer acquisition channel and a switching cost driver.
Medisca operates a direct B2B model with enterprise field sales, account-registration-gated pricing, pay-as-you-go billing, and supplementary wholesale distribution. Revenue derives primarily from one-time product sales of pharmaceutical-grade ingredients, with secondary streams from professional services (education, training, consulting, formulation support). The company is privately held with no public ticker, no disclosed funding rounds, and no external investor information available. Recent strategic activity includes the May 2026 partnership with dsm-firmenich for pharmaceutical-grade vitamin APIs, an upcoming launch in Germany via subsidiary Medisca GmbH (offices in Schkopau and Teutschenthal), and the 2022 acquisition of Maxima Pharmaceuticals.
Medisca firmographics
Firmographics- Name
- Medisca
- Legal name
- Medisca Inc.
- Website
- https://medisca.com
- Company type
- Private
- Founded year
- 1989
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Medisca is a privately held pharmaceutical compounding solutions provider founded in 1989, distributing 2,000+ APIs, chemicals, and compounding supplies to pharmacies, outsourcing facilities, hospitals, and healthcare providers globally, supported by formulation, education, and compliance services.
- Ownership category
- akta.pro rank
Medisca industry classification
Industry- Product category
- Pharmaceutical Compounding
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Medication Inventory, Procurement & Supply Chain (Pharmacy) (HLACAKAI)
Keywords
Where Medisca is headquartered
LocationHeadquarters
- HQ city
- Plattsburgh
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Medisca business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Pharmaceutical Compounding Products: B2B sales of pharmaceutical-grade active pharmaceutical ingredients, compounding bases, vehicles, capsules, chemicals, controlled substances, devices, equipment, flavors, colors, and oils to compounding pharmacies, laboratories, and healthcare providers
- Education and Training Services: Fee-based educational programs including self-paced online learning, seminars, webinars, hands-on lab training, and provider portals for continuing professional education in pharmaceutical compounding
- Consulting Services: Specialized consultations and formulation support services for compounding pharmacy professionals
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Account-based B2B pricing |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Medisca product offering
Product offeringCore offering
Medisca is a global supplier of pharmaceutical compounding solutions, offering a portfolio of over 2,000 products including active pharmaceutical ingredients (APIs), bases and vehicles, capsules, chemicals, controlled substances, devices, equipment, flavors, colors, oils, and laboratory supplies. The company complements its physical product catalog with formulation support services, specialized consultations, standard operating procedures, analytical testing, and a comprehensive education catalog covering self-paced online learning, seminars, webinars, and hands-on lab training for compounding pharmacy professionals.
Product overview
Medisca is a global pharmaceutical compounding solutions provider offering over 2,000 products across a unified platform-plus-services model. The core product portfolio includes active pharmaceutical ingredients (APIs) such as pharmaceutical-grade vitamin APIs from the dsm-firmenich partnership, chemical ingredients, bases and vehicles, capsules, controlled substances, devices, equipment, flavors, colors, oils, and lab supplies. The company complements its product offerings with formulation support services, standard operating procedures, specialized consultations, and a comprehensive education catalog (self-paced online learning, seminars, webinars, hands-on lab training, provider portals). Supporting resources include a formula library, BUDs library, studies library, and Compounding 101 educational materials. Medisca serves 503A Pharmacies, 503B Outsourcing facilities, cannabis industry, contract manufacturing, hospitals and clinics, physicians and providers, telehealth, and wholesalers.
Differentiator
Problem solved
Functional benefit
Products and services
- Active Pharmaceutical Ingredients (APIs)
Quantifiable outcome
- Over 2,000 products in portfolio meeting global quality standards
- +1 more outcomes
Companies that use Medisca
Customer profileNamed customers9 records
Segments9 records
Ideal customer profiles5 records
Medisca technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Medisca partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- dsm-firmenichcoreMedisca entered into a strategic partnership with dsm-firmenich to make pharmaceutical-grade vitamin active pharmaceutical ingredients (APIs) available to U.S. compounding professionals. This partnership expands access to ingredients manufactured within European cGMP environments, addressing the growing demand for high-quality APIs in the compounding pharmacy market. The collaboration enables Medisca to offer pharmaceutical-grade vitamin APIs to their network of compounding pharmacies and healthcare providers.
Scale indicators3 records
Recent moves5 records
Expansion highlights6 records
Medisca competitors and assessment
Company assessmentDirect peers
- Letco Medical (LGM Pharma): Letco Medical supplies APIs, excipients, equipment and supplies to compounding pharmacies and 503B outsourcing facilities. It is a direct specialty competitor in the U.S. compounding supply channel.
- Fagron: Fagron is the largest global supplier of pharmaceutical compounding raw materials, APIs, equipment and education services. It directly competes with Medisca across 503A/503B pharmacies, hospitals and outsourcing facilities in the same product categories.
- Spectrum Chemical Mfg. Corp. Spectrum Chemical supplies high-purity chemicals, APIs and laboratory supplies to pharmaceutical, compounding and research customers. It overlaps with Medisca's chemicals, APIs and lab supplies categories for compounding and laboratory buyers.
- PCCA (Professional Compounding Centers of America): PCCA is a leading U.S. supplier of APIs, bases, devices and clinical education for compounding pharmacies. It competes head-to-head with Medisca's 503A pharmacy offering and shares a similar education-and-content go-to-market approach.
Broad incumbents
- McKesson Corporation: McKesson is the largest U.S. pharmaceutical wholesaler and distributor. While it focuses on finished drug distribution rather than compounding APIs, its scale and breadth allow it to compete for hospital and pharmacy wallet share adjacent to Medisca's products.
- Cardinal Health: Cardinal Health distributes pharmaceuticals and medical products to hospitals, pharmacies and healthcare providers. Its at-home solutions and nuclear pharmacy services touch the same end customers Medisca serves via compounding.
- AmerisourceBergen (Cencora): Cencora (formerly AmerisourceBergen) is a top-tier pharmaceutical distributor with global reach. It overlaps with Medisca in wholesale distribution of compounding-related drugs and supplies through its MWI Animal Health and specialty distribution arms.
- Becton, Dickinson and Company (BD): BD manufactures medical devices, injection systems and drug delivery products used by hospitals, compounding pharmacies and 503B outsourcing facilities. It overlaps with Medisca's devices and equipment category for pharmacy compounding workflows.
Others
- dsm-firmenich: dsm-firmenich is Medisca's strategic partner for pharmaceutical-grade vitamin APIs manufactured in European cGMP environments. As a supplier and collaborator (not a competitor), it shapes Medisca's API quality positioning and access to premium ingredients.
- Thermo Fisher Scientific: Thermo Fisher supplies laboratory chemicals, analytical instruments and research consumables that overlap with Medisca's lab supplies and chemicals categories for research and laboratory customers. It is an enabling supplier rather than a direct channel competitor.
Market position
Strengths1 record
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Medisca social profiles
Digital presenceMedisca compliance and trust
Trust signalCompliance1 record
Medisca financial estimates
Financial estimateRevenue estimate
Valuation estimate
Medisca leadership team
Management profileNumber of profiles
Medisca funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Medisca M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Medisca
What does Medisca do?
Medisca is a global supplier of pharmaceutical compounding solutions, offering a portfolio of over 2,000 products including active pharmaceutical ingredients (APIs), bases and vehicles, capsules, chemicals, controlled substances, devices, equipment, flavors, colors, oils, and laboratory supplies. The company complements its physical product catalog with formulation support services, specialized consultations, standard operating procedures, analytical testing, and a comprehensive education catalog covering self-paced online learning, seminars, webinars, and hands-on lab training for compounding pharmacy professionals.
Is Medisca a public or private company?
Medisca is a private company. It is classified as unknown and is currently operating.
When was Medisca founded?
Medisca was founded in 1989. It employs 251 to 500 people.
Where is Medisca based?
Medisca is headquartered in Plattsburgh, United States, in the North America region.
How does Medisca make money?
Three revenue lines are on record. Pharmaceutical Compounding Products are the primary driver. The others are education and Training Services and consulting Services.
Who are Medisca's main competitors?
Direct peers on record are Letco Medical (LGM Pharma), Fagron, Spectrum Chemical Mfg. Corp. and PCCA (Professional Compounding Centers of America). Broad incumbents are McKesson Corporation, Cardinal Health, AmerisourceBergen (Cencora) and Becton, Dickinson and Company (BD). Others are dsm-firmenich and Thermo Fisher Scientific.
Does Medisca have an API?
No public API is recorded for Medisca.
What industry is Medisca in?
Medisca's product category is Pharmaceutical Compounding. Its primary akta.pro industry code is HLACAKAI, Medication Inventory, Procurement & Supply Chain (Pharmacy). Its NAICS code is 325412 and its SIC code is 2834.